SCHEMBL8009599

SCHEMBL8009599

C[N]C(=O)CCCCCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.65
RXFP1 Q9HBX9 1/20 0.65
HDAC1 Q13547 4/20 0.57
ALOX5 P09917 3/20 0.57
HDAC2 Q92769 2/20 0.57
FAAH O00519 3/20 0.56
CES1 P23141 3/20 0.56
HDAC3 O15379 1/20 0.53
MAPK1 P28482 1/20 0.53
ADRA1A P35348 1/20 0.53
HDAC4 P56524 1/20 0.53
SLC6A3 Q01959 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC10 Q969S8 1/20 0.53
HDAC11 Q96DB2 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HDAC9 Q9UKV0 1/20 0.53
HDAC5 Q9UQL6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2487165 0.85 ALDH1A1 (0.61) MAPTRXFP1HDAC1HDAC2HDAC3
SCHEMBL16751107 0.81 MAPT (0.63) MAPTRXFP1HDAC1ALOX5HDAC2
SCHEMBL6213668 0.79 MAPT (0.71) MAPTRXFP1HDAC1ALOX5HDAC2
SCHEMBL8104136 0.79 MAPT (0.71) MAPTRXFP1HDAC1ALOX5HDAC2
SCHEMBL5681573 0.79 MAPT (0.71) MAPTRXFP1HDAC1ALOX5HDAC2
SCHEMBL24340640 0.79 MAPT (0.71) MAPTRXFP1HDAC1ALOX5HDAC2
SCHEMBL13498521 0.79 MAPT (0.71) MAPTRXFP1HDAC1ALOX5HDAC2
SCHEMBL2632727 0.79 MAPT (0.71) MAPTRXFP1HDAC1ALOX5HDAC2
SCHEMBL547835 0.79 MAPT (0.71) MAPTRXFP1HDAC1ALOX5HDAC2
SCHEMBL12040622 0.79 MAPT (0.71) MAPTRXFP1HDAC1ALOX5HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed